![]() |
|
|
Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland
Endocannabinoids may serve as retrograde messengers to inhibit neurotransmitter release during depolarization-induced suppression of inhibition (DSI) or excitation (DSE). We therefore tested whether endocannabinoids inhibit N-type voltage-dependent Ca2+ channels by activating Gi/o-protein-coupled CB1 cannabinoid receptors (CB1R)a possible mechanism underlying DSI/DSE. Three putative endocannabinoids [2-arachidonylglycerol (2-AG), 2-arachidonyl glycerol ether (2-AGE), and anandamide (AEA)] and the cannabimimetic aminoalkylindole WIN 55,212-2 (WIN) inhibited whole-cell Ca2+ currents in rat sympathetic neurons previously injected with cDNA encoding a human CB1R. Agonist-mediated Ca2+ current inhibition was blocked by a selective CB1R antagonist [SR141716A, N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboximide hydrochloride] and pertussis toxin (PTX) pretreatment. The rank order of potency was WIN (IC50 = 2 nM) > 2-AGE (350 nM)
2-AG (480 nM) > AEA (
3 µM), with each agonist displaying similar efficacy (approximately 50% maximal inhibition). Increasing CB1R expression level significantly enhanced AEA potency. AEA (10 µM) also inhibited Ca2+ channels in a voltage-independent, CB1R-independent, and PTX-insensitive manner, whereas 2-AG and 2-AGE were devoid of this activity. All three endocannabinoids activated G-protein-coupled inwardly rectifying potassium (GIRK) channels, GIRK1/4, heterologously expressed in sympathetic neurons. These results suggest a mechanism by which endocannibinoids might influence presynaptic function.
Address correspondence to: Stephen R. Ikeda, M.D., Ph.D., Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, Park Building Room 150, 12420 Parklawn Drive MSC 8115, Bethesda, MD 20892-8815. E-mail: sikeda{at}mail.nih.gov
This article has been cited by other articles:
![]() |
P. W. Wacnik, K. M. Luhr, R. H. Hill, H.-G. Ljunggren, K. Kristensson, and M. Svensson Cannabinoids Affect Dendritic Cell (DC) Potassium Channel Function and Modulate DC T Cell Stimulatory Capacity J. Immunol., September 1, 2008; 181(5): 3057 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, D. J. Williams, and S. R. Ikeda N-Arachidonoyl L-Serine, a Putative Endocannabinoid, Alters the Activation of N-Type Ca2+ Channels in Sympathetic Neurons J Neurophysiol, August 1, 2008; 100(2): 1147 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sheinin, G. Talani, M. I. Davis, and D. M. Lovinger Endocannabinoid- and mGluR5-Dependent Short-Term Synaptic Depression in an Isolated Neuron/Bouton Preparation From the Hippocampal CA1 Region J Neurophysiol, August 1, 2008; 100(2): 1041 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, D. J. Williams, H. L. Puhl III, and S. R. Ikeda Inhibition of N-Type Calcium Channels by Activation of GPR35, an Orphan Receptor, Heterologously Expressed in Rat Sympathetic Neurons J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 342 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oka, S. Arai, K. Waku, A. Tokumura, and T. Sugiura Depolarization-induced Rapid Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Rat Brain Synaptosomes J. Biochem., May 1, 2007; 141(5): 687 - 697. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Neu, C. Foldy, and I. Soltesz Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus J. Physiol., January 1, 2007; 578(1): 233 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Yin and D. M. Lovinger Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling PNAS, May 23, 2006; 103(21): 8251 - 8256. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Zhu and D. M. Lovinger Retrograde Endocannabinoid Signaling in a Postsynaptic Neuron/Synaptic Bouton Preparation from Basolateral Amygdala J. Neurosci., June 29, 2005; 25(26): 6199 - 6207. [Abstract] [Full Text] [PDF] |
||||